US 10980889
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
granted A61KA61K31/436A61K31/519
Quick answer
US patent 10980889 (C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors) held by Revolution Medicines, Inc. expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Revolution Medicines, Inc.
- Grant date
- Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/436, A61K31/519, A61K31/553, A61K47/545